Carregant...

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Taylor, Matthew, Antonia, Scott, Bendell, Johanna, Calvo, Emiliano, Jäger, Dirk, de Braud, Filippo, Ott, Patrick A, Pietanza, M Catherine, Horn, Leora, Le, Dung T, Morse, Michael A, López-Martin, José A, Ascierto, Paolo A, Christensen, Olaf, Simon, Jason S, Lin, Chen-Sheng, Eder, Joseph Paul
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649441/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P376
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!